Hively Brad — SEC insider filings
SEC reporting owner CIK 1891124. 24 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-11-16 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 354,336 shares, $106,602 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 2,390,262 shares, $7,945,091 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 1,867,605 shares @ $2.87 ($5,360,587) in Starling Oncology, Inc., filed 2025-06-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | Director | 24 | 4 legs · 354,336 sh · $106,602 | 8 legs · 2,390,262 sh · $7,945,091 | 38 |
Insider filings — Hively Brad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Starling Oncology, Inc. (STLN) | Sale (S): 298,853 @ $6.51 | EDGAR |
| 2026-07-29 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 27,108 @ $0 | EDGAR |
| 2025-12-16 | 4 | Oncology Institute, Inc. (TOI) | Sale (S): 13,333 @ $3.77 | EDGAR |
| 2025-11-24 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 41,667 @ $0 · Grant/award (A): 32,407 @ $0 | EDGAR |
| 2025-08-21 | 4 | Oncology Institute, Inc. (TOI) | Sale (S): 20,221 @ $4.06 | EDGAR |
| 2025-06-05 | 4 | Oncology Institute, Inc. (TOI) | Option exercise (M): 684,528 @ $0.85 · Option exercise (M): 105,320 @ $0.48 · Option exercise (M): 131,297 @ $1.87 · Option exercise (M): 946,460 @ $0.85 · Sale (S): 1,867,605 @ $2.87 · Sale (S): 108,532 @ $2.87 · +4 more | EDGAR |
| 2025-04-28 | 4/A | Oncology Institute, Inc. (TOI) | Purchase (P): 45,280 @ $1.04 · Purchase (P): 22,640 (derivative) @ $0.12 | EDGAR |
| 2025-03-28 | 4 | Oncology Institute, Inc. (TOI) | Purchase (P): 9,056 @ $1.04 · Purchase (P): 4,528 (derivative) @ $0.12 | EDGAR |
| 2024-12-02 | 4 | Oncology Institute, Inc. (TOI) | Other (J): 353,450 @ $0 · Purchase (P): 250,000 @ $0.17 · Purchase (P): 50,000 @ $0.15 | EDGAR |
| 2024-11-25 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 44,000 @ $0 | EDGAR |
| 2024-06-20 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 18,121 @ $0.46 | EDGAR |
| 2024-05-23 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 19,526 @ $0.58 | EDGAR |
| 2023-12-28 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 42,652 @ $0 | EDGAR |
| 2023-11-22 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 25,867 @ $2.19 | EDGAR |
| 2023-11-21 | 4 | Oncology Institute, Inc. (TOI) | Option exercise (M): 25,000 @ $0.85 · Sale (S): 25,000 @ $2.24 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2023-11-15 | 4 | Oncology Institute, Inc. (TOI) | Option exercise (M): 47,000 @ $0.85 · Sale (S): 47,000 @ $2.52 · Disposition to issuer (D): 27,117 @ $2.39 · Option exercise (M): 47,000 (derivative) @ $0 | EDGAR |
| 2023-03-21 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 168,512 @ $0 · Grant/award (A): 421,280 (derivative) @ $0 | EDGAR |
| 2022-11-22 | 4/A | Oncology Institute, Inc. (TOI) | Sale (S): 9,718 @ $2.03 | EDGAR |
| 2022-11-21 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 103,469 @ $0 · Grant/award (A): 525,188 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 9,718 @ $2.03 | EDGAR |
| 2022-03-29 | 4/A | Oncology Institute, Inc. (TOI) | Grant/award (A): 550,563 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 108,469 @ $0 · Grant/award (A): 88,090 (derivative) @ $0 | EDGAR |
| 2021-11-18 | 4/A | Oncology Institute, Inc. (TOI) | Grant/award (A): 141,380 @ $0 · Grant/award (A): 212,070 @ $0 | EDGAR |
| 2021-11-16 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 141,380 @ $0 · Grant/award (A): 212,070 @ $0 · Grant/award (A): 993,460 (derivative) @ $0 · Grant/award (A): 823,971 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-11-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1891124 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs